Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000691869 | SCV000819665 | benign | Tuberous sclerosis 2 | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025100 | SCV005036393 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-02-10 | criteria provided, single submitter | clinical testing | The p.S1002F variant (also known as c.3005C>T), located in coding exon 26 of the TSC2 gene, results from a C to T substitution at nucleotide position 3005. The serine at codon 1002 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |